The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders.

Juncà Piera J(Hospital Universitari Germans Trias i Pujol), Evarist Feliú(Universitat Autònoma de Barcelona), Francisco Fernández‐Avilés, José‐Tomás Navarro(Universitat Autònoma de Barcelona), Albert Oriol(Institut Català d'Oncologia), Fuensanta Millá, Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol)
PubMed
August 1, 1998
Cited by 39

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
|Blood|2014|429
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2019|386